当前位置：首页 > 文献互助 > 互助详情

Reversible Michael Additions: Covalent Inhibitors and Prodrugs复制

用户OEolK0cUqpBE 50分钟前 7 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-08-10 15:43:45 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.2174/13895575112091330复制

文献链接: http://www.eurekaselect.com/openurl/content.php?genre=article复制

其他信息:

出版社: Bentham Science Publishers Ltd.
作者: Martin H. Johansson

上一篇：Modern Principles of Brachytherapy Physics

下一篇：Discovery of 4-((2S,5R)-2-((difluoromethoxy)methyl)-5-(4-(trifluoromethyl)phenyl)piperidin-1-yl)-N-((R)-1-(4-(ethylsulfonyl)phenyl)-2-hydroxyethyl)benzamide as a potent, orally available RORγt inverse agonist

互助时间线

2026-08-03 15:47:58 [完结求助]

楼主确认了文献分析应助的文件是正确的, 求助状态变成 已完结

2026-08-03 15:43:45 [上传文件]

文献分析上传了文件(pdf 334.13 KB), 求助状态变成 待确认

2026-08-03 15:43:37 [发起求助]

最新发布的求助

Fibroblast Activation Protein-α 1分钟前
Nutrition and Metabolism of Dogs and Cats 30分钟前
Discovery of 4-((2S,5R)-2-((difluoromethoxy)methyl)-5-(4-(trifluoromethyl)phenyl)piperidin-1-yl)-N-((R)-1-(4-(ethylsulfonyl)phenyl)-2-hydroxyethyl)benzamide as a potent, orally available RORγt inverse agonist 45分钟前
Reversible Michael Additions: Covalent Inhibitors and Prodrugs 50分钟前
Modern Principles of Brachytherapy Physics 1小时前
Development of a flow cytometry method to measure antidrug antibodies against CAR T cells 1小时前
Synthesis of (Hetero)aryl/Alkenyl Iodides via Ni-CatalyzedFinkelstein Reaction from Bromides or Chlorides 1小时前
[Synthesis and study of B-nor-8-isoanalogs of steroid estrogens]. 1小时前
Bioactive powder adhesive featuring clotting synergy for alveolar extraction socket hemostasis and regeneration 1小时前
Safety and pharmacokinetics of efinaconazole 10% solution in healthy volunteers and patients with severe onychomycosis 2小时前
Ifebemtinib plus garsorasib as first-line treatment for KRASG12C-mutated non-small-cell lung cancer in China: a multicentre, single-arm expansion cohort from a phase 1b/2 trial 2小时前
Plasma surface engineering for efficient and stable perovskite solar cells and modules 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com